Safety and tolerability of intravenous regadenoson in healthy subjects: A randomized, repeat-dose, placebo-controlled study

BACKGROUND: Regadenoson is a selective A(2A) adenosine receptor agonist indicated for radionuclide myocardial perfusion imaging in patients unable to undergo adequate exercise stress. However, the safety, tolerability, and plasma concentrations associated with repeated doses have not previously been...

Descripción completa

Detalles Bibliográficos
Autores principales: Townsend, Robert, Desai, Amit, Rammelsberg, Diane, Kowalski, Donna, Simmons, Neal, Kitt, Therese M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5250646/
https://www.ncbi.nlm.nih.gov/pubmed/26607361
http://dx.doi.org/10.1007/s12350-015-0327-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5250646/
https://www.ncbi.nlm.nih.gov/pubmed/26607361
http://dx.doi.org/10.1007/s12350-015-0327-9

Ejemplares similares